相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4
Peng Liao et al.
CANCER CELL (2022)
Copper induces cell death by targeting lipoylated TCA cycle proteins
Peter Tsvetkov et al.
SCIENCE (2022)
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Valentina Oliveri
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
Liyang Cui et al.
NATURE BIOTECHNOLOGY (2021)
Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis
Yanchun Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma
Huabo Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma et al.
CELL METABOLISM (2021)
Cirrhotic Liver of Liver Transplant Recipients Accumulate Silver and Co-Accumulate Copper
Jaroslaw Poznanski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays
Fan Zhang et al.
CANCER CELL INTERNATIONAL (2021)
Murine deficiency of peroxisomal l-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis
Pablo Ranea-Robles et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study
Zhenggang Ren et al.
LANCET ONCOLOGY (2021)
Role of Copper on Mitochondrial Function and Metabolism
Lina M. Ruiz et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis
Xi Zhang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2021)
SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC
Qingzhu Gao et al.
CELL DEATH AND DIFFERENTIATION (2020)
The enhancement of glycolysis regulates pancreatic cancer metastasis
Jinshou Yang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Pyroptosis: A new frontier in cancer
Yuan Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A hydrogen peroxide -activated Cu(II) pro-ionophore strategy for modifying naphthazarin as a promising anticancer agent with high selectivity for generating ROS in HepG2 cells over in L02 cells
Xia-Zhen Bao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Metabolism-associated molecular classification of hepatocellular carcinoma
Chen Yang et al.
MOLECULAR ONCOLOGY (2020)
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Michael A. Badgley et al.
SCIENCE (2020)
Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma
Tiffany Tsang et al.
NATURE CELL BIOLOGY (2020)
Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation
Aniko Gaal et al.
PHARMACEUTICS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Copper homeostasis: Emerging target for cancer treatment
Yueqin Li
IUBMB LIFE (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancer
Shaoquan Zheng et al.
MOLECULAR ONCOLOGY (2020)
Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosis
Junjun Zhang et al.
LIFE SCIENCES (2020)
Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment
Hui Qu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Yang Liu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation
Caroline Davis et al.
METALLOMICS (2020)
Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
Junhui Yu et al.
CELL DEATH & DISEASE (2019)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells
Fei Chen et al.
NATURE CELL BIOLOGY (2019)
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
Antonio Gnoni et al.
MEDICINA-LITHUANIA (2019)
Targeting redox vulnerability of cancer cells by prooxidative intervention of a glutathione-activated Cu(II) pro-ionophore: Hitting three birds with one stone
Xia-Zhen Bao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Amy Tarangelo et al.
CELL REPORTS (2018)
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu et al.
CANCER RESEARCH (2018)
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2
Yanhong Zhang et al.
GENES & DEVELOPMENT (2017)
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Yangchun Xie et al.
CELL REPORTS (2017)
Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors
Donita C. Brady et al.
CANCER RESEARCH (2017)
Accumulated Metabolites of Hydroxybutyric Acid Serve as Diagnostic and Prognostic Biomarkers of Ovarian High-Grade Serous Carcinomas
Mika Hilvo et al.
CANCER RESEARCH (2016)
Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Xiaofang Sun et al.
HEPATOLOGY (2016)
Apoptosis, autophagy, necroptosis, and cancer metastasis
Zhenyi Su et al.
MOLECULAR CANCER (2015)
Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells
Yuan-Fei Peng et al.
AUTOPHAGY (2013)
Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
Steven J. O'Day et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor glycolysis as a target for cancer therapy: progress and prospects
Shanmugasundaram Ganapathy-Kanniappan et al.
MOLECULAR CANCER (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Copper Oxide Nanoparticles Induced Mitochondria Mediated Apoptosis in Human Hepatocarcinoma Cells
Maqsood A. Siddiqui et al.
PLOS ONE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis
Yanbo Shi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Inherited Copper Transport Disorders: Biochemical Mechanisms, Diagnosis, and Treatment
Hiroko Kodama et al.
CURRENT DRUG METABOLISM (2012)
Autophagy and metastasis: another double-edged sword
Candia M. Kenific et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
Human catalase: looking for complete identity
Madhur M. Goyal et al.
PROTEIN & CELL (2010)
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
J. Thorburn et al.
CELL DEATH AND DIFFERENTIATION (2009)
Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma
Steven O'Day et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity
Di Chen et al.
CANCER RESEARCH (2006)
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Kurt Degenhardt et al.
CANCER CELL (2006)
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
DZ Cen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
分享论文
